BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
118 results:

  • 1. Pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferation.
    Nishimon R; Yoshida K; Sanuki F; Nakashima Y; Miyake T; Sato T; Tomiyama Y; Nishina S; Moriya T; Shiotani A; Hino K
    Pancreatology; 2023 Nov; 23(7):811-817. PubMed ID: 37659916
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The prognostic role of epidermal growth factor receptor mutation in completely resected ampullary adenocarcinoma.
    Varol U; Cakır E; Aktas S; Altun ZS; Dilek FH; Butun O; Salman T; Unlu AGD; Alacacioglu A; Somali I
    Pol J Pathol; 2023; 74(1):18-28. PubMed ID: 37306349
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic cancer Cells Through Inhibition of muc1 Expression.
    Wei D; Wang L; Liu Y; Hafley MA; Tan L; Lorenzi PL; Yang P; Zuo X; Bresalier RS
    Dig Dis Sci; 2023 Jul; 68(7):3043-3058. PubMed ID: 37071246
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines.
    Tamburello M; Abate A; Rossini E; Basnet RM; Zizioli D; Cosentini D; Hantel C; Laganà M; Tiberio GAM; Grisanti S; Memo M; Berruti A; Sigala S
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047801
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
    Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
    Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma.
    Qian Y; Gong Y; Liu Y; Chen Y; Wang R; Dai Z; Zou X; Tasiheng Y; Luo G; Lin X; Wang X; Cheng H; Yu X; Liu C
    J Immunol Res; 2022; 2022():7353572. PubMed ID: 35910854
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
    Xu W; Zhang M; Liu L; Yin M; Xu C; Weng Z
    PLoS One; 2022; 17(6):e0269612. PubMed ID: 35709153
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Clinicopathological and Molecular Analysis of Sellar/Suprasellar Neurocytoma Mimicking Pituitary Adenoma.
    Zhang L; Fu W; Zheng L; Song F; Chen Y; Jiang C; Xing Z; Hu C; Ye Y; Zhang S; Yan X; Wang X
    Front Endocrinol (Lausanne); 2022; 13():861540. PubMed ID: 35663322
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. pumILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.
    Li X; Zhu M; Zang M; Cao D; Xie Z; Liang H; Bian Z; Zhao T; Hu Z; Xu EY
    Cell Mol Life Sci; 2022 May; 79(5):279. PubMed ID: 35507203
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic cancer.
    Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
    DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Comprehensive Analysis of Tripterine Anti-Ovarian cancer Effects Using Weighted Gene Co-Expression Network Analysis and Molecular Docking.
    Long X; Liu L; Zhao Q; Xu X; Liu P; Zhang G; Lin J
    Med Sci Monit; 2022 Jan; 28():e932139. PubMed ID: 35022380
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or muc1 peptide-loaded dendritic cell vaccination and a standard chemotherapy.
    Ota S; Miyashita M; Yamagishi Y; Ogasawara M
    Hum Vaccin Immunother; 2021 Dec; 17(12):5563-5572. PubMed ID: 34919493
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. muc1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas.
    Luan Z; Morimoto Y; Fushimi A; Yamashita N; Suo W; Bhattacharya A; Hagiwara M; Jin C; Kufe D
    Carcinogenesis; 2022 Feb; 43(1):67-76. PubMed ID: 34657147
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. IgE-Based Therapeutic Combination Enhances Antitumor Response in Preclinical Models of Pancreatic cancer.
    Markov SD; Caffrey TC; O'Connell KA; Grunkemeyer JA; Shin S; Hanson R; Patil PP; Shukla SK; Gonzalez D; Crawford AJ; Vance KE; Huang Y; Eberle KC; Radhakrishnan P; Grandgenett PM; Singh PK; Madiyalakan R; Daniels-Wells TR; Penichet ML; Nicodemus CF; Poole JA; Jaffee EM; Hollingsworth MA; Mehla K
    Mol Cancer Ther; 2021 Dec; 20(12):2457-2468. PubMed ID: 34625505
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid cancer: Evaluation of the Preclinical Rationale.
    Adam P; Kircher S; Sbiera I; Koehler VF; Berg E; Knösel T; Sandner B; Fenske WK; Bläker H; Smaxwil C; Zielke A; Sipos B; Allelein S; Schott M; Dierks C; Spitzweg C; Fassnacht M; Kroiss M
    Front Endocrinol (Lausanne); 2021; 12():712107. PubMed ID: 34475850
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
    Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
    Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center phase I/II trial.
    Ogasawara M; Miyashita M; Yamagishi Y; Ota S
    Ther Apher Dial; 2021 Aug; 25(4):415-424. PubMed ID: 33886156
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A case of intraductal tubulopapillary neoplasm of the pancreas in a branch duct: a rare case report and literature review.
    Yamaguchi A; Hamada T; Wada K; Moriuchi R; Tao K; Konishi H; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Ishiyama K; Hadano N; Sudo T; Toyota N; Zaitsu J; Kuraoka K; Kohno H
    BMC Gastroenterol; 2021 Apr; 21(1):162. PubMed ID: 33849435
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Expression of CD117, CK17, CK20, MUC4, villin and mismatch repair deficiency in pancreatic intraductal papillary mucinous neoplasm.
    Detlefsen S; Jakobsen M; Nielsen MFB; Klöppel G; Mortensen MB
    Pathol Res Pract; 2021 Jan; 217():153312. PubMed ID: 33341087
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and therapy.
    Wang S; You L; Dai M; Zhao Y
    J Cell Mol Med; 2020 Sep; 24(18):10279-10289. PubMed ID: 32745356
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.